Adage Capital Partners Gp, L.L.C. Nevro Corp Transaction History

Adage Capital Partners Gp, L.L.C.

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$40.66 - $53.03 $8.13 Million - $10.6 Million	200,000 New	200,000 $9.32 Million
Q3 2020 Nov 16, 2020	SELL	$114.09 - $145.51 $5.13 Million - $6.55 Million	-45,000 Closed	0 $0
Q2 2020 Aug 14, 2020	SELL	$89.45 - $129.85 $4.92 Million - $7.14 Million	-55,000 Reduced 55.0%	45,000 $5.38 Million
Q1 2020 May 15, 2020	SELL	$70.23 - $144.31 $8.43 Million - $17.3 Million	-120,000 Reduced 54.55%	100,000 $10 Million
Q4 2019 Feb 14, 2020	SELL	$76.41 - $117.54 $2.29 Million - $3.53 Million	-30,000 Reduced 12.0%	220,000 $25.9 Million
Q3 2019 Nov 14, 2019	SELL	$61.52 - $91.1 $15.4 Million - $22.8 Million	-250,000 Reduced 50.0%	250,000 $21.5 Million
Q2 2019 Aug 14, 2019	SELL	$58.04 - $66.99 $11.6 Million - $13.4 Million	-200,000 Reduced 28.57%	500,000 $32.4 Million
Q1 2019 May 15, 2019	BUY	$35.52 - $62.62 $21 Million - $37.1 Million	592,500 Added 551.16%	700,000 $43.8 Million
Q4 2018 Feb 14, 2019	BUY	$35.43 - $56.29 $3.81 Million - $6.05 Million	107,500 New	107,500 $4.18 Million
Q3 2018 Nov 14, 2018	SELL	$44.22 - $75.47 $8.84 Million - $15.1 Million	-200,000 Closed	0 $0
Q2 2018 Aug 14, 2018	BUY	$72.38 - $92.5 $5.43 Million - $6.94 Million	75,000 Added 60.0%	200,000 $16 Million
Q1 2018 May 15, 2018	BUY	$69.46 - $88.57 $8.68 Million - $11.1 Million	125,000 New	125,000 $10.8 Million
Q4 2017 Feb 14, 2018	SELL	$65.94 - $93.31 $9.89 Million - $14 Million	-150,000 Closed	0 $0
Q3 2017 Nov 14, 2017	BUY	$80.87 - $91.08 $12.1 Million - $13.7 Million	150,000	150,000 $13.6 Million

151

39.3M

67.9K

1.59M

Ticker NVRO
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 35,387,800
Market Cap $133M
Description
Nevro Corp., a medical device company, provides products for patients suffering from chronic pain in the United States and internationally. The company develops and commercializes the Senza spinal cord stimulation system, an evidence-based neuromodulation platform for the treatment of chronic pain, as well as Senza II and Senza Omnia systems. It...

Get notified when there are updates to the investment portfolio of Adage Capital Partners Gp, L.L.C., based on Form 13F filings with the SEC.

Stay updated on Adage Capital Partners Gp, L.L.C. with notifications on news.